1. Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF‐β1/pERK signaling pathway. Issue 3 (28th December 2022) Authors: Deza, Zahira; Caimi, Giselle Romero; Noelia, Miret; Coli, Lucia; Ridruejo, Ezequiel; Alvarez, Laura Journal: Molecular carcinogenesis Issue: Volume 62:Issue 3(2023) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗